Tissue Engineering & Regenerative Medicine Research Program

The Tissue Engineering and Regenerative Medicine Program supports basic and translational research on employing bioengineering- and stem cell biology- based approaches for the reconstruction, repair, and regeneration of dental, oral, and craniofacial (DOC) tissues damaged because of disease or injury. The goal of this program is to advance engineering of biocompatible DOC tissue constructs and their functional integration into the host tissue microenvironment, and to support efforts aimed at healing and regeneration of endogenous host tissues.

Staff Contacts

Funding Opportunity Announcements

Title Staff contact Opportunity number Activity Code Application due date
Regenerative Medicine Innovation Projects (RMIP) (U44 - Clinical Trial Not Allowed) RFA-HL-18-035 U44
Regenerative Medicine Innovation Projects (RMIP) (UT2 - Clinical Trial Not Allowed) RFA-HL-18-033 U44
Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) RFA-HL-18-031 UG3, UH3
Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01 Clinical Trial Not Allowed) RFA-HL-18-030 U01
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-18-837 R41, R42, R43
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-18-591 C06, D43, D71
Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed) PA-18-817 C06
NIH Directors Transformative Research Award (R01 - Clinical Trial Optional) RFA-RM-18-009 D71, R01
NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional) RFA-RM-18-008 DP2
Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) PA-18-591 C06, D43, D71
Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations (Admin Supp) PA-18-713 C06, D43, D71
Administrative Supplement for Research on Sex/Gender Influences (Admin Supp - Clinical Trial Optional) PA-18-658 DP1, DP2, DP4
PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) PA-18-576 R41, R42
PHS 2018-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) PA-18-575 R41, R42
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PA-18-574 R43, R44
Opportunities for Collaborative Research at the NIH Clinical Center (U01 - Clinical Trial Optional) PAR-18-646 U01
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) PA-18-648 R13
Administrative Supplements for Research on Dietary Supplements (Admin Supp) PA-17-307 P30, P40, P50
Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed) PA-18-504 R15
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) PA-18-489 R21
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) PA-18-484 R01
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01) PAR-16-093 R01
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21) PAR-16-094 R21
Tools for Cell Line Identification (R43/R44) PA-16-186 R43, R44
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) PA-17-148 R41, R42
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) PAR-15-344 R03
Change of Grantee Organization (Type 7 Parent) PA-16-285 C06, D43, D71
Successor-in-Interest (Type 6 Parent) PA-16-286 C06, D43, D71
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) PA-16-289 DP1, DP2, DP3
NIDCR Small Grant Program for New Investigators (R03) PAR-16-409 R03
SBIR Technology Transfer (R43/R44) PA-15-354 R43, R44
Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R43/R44) PA-16-180 R43, R44
Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R41/R42) PA-16-181 R41, R42
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) PA-17-147 R43, R44
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)s PA-16-040 R21
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) PAR-16-288 DP1, DP2, DP3